BUZZ-Jazz Pharmaceuticals Plc: Acquires rights to liver drug

Wed Jul 2, 2014 9:40am EDT

** Drugmaker's shares up 2 pct at $154.99

** Acquires U.S. marketing rights for liver drug defibrotide in the U.S. from privately held Sigma Tau Pharmaceuticals Inc for $75 million

** Defibrotide treats complications in the liver, caused from high-dose chemotherapy given to patients undergoing stem cell transplantation

** Jazz already sells the drug in the European Union under the brand name Defiteli

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article